Brett Carter is the CEO of the Cancer Therapeutics CRC and he joins us in the MTPConnect podcast studio to chat his team’s work, their project to build a comprehensive drug discovery library and the growing importance of cancer immunotherapy.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
